Genocea

Genocea is a pharmaceutical company that researches and develops T-cell based therapies for the treatment of cancer.

Business Model:

Revenue: $1.6M

Employees: 51-200

Detailed Genocea Information

Geographic Data

Genocea headquarters map

Address: 100 Acorn Park Drive

City: Cambridge

State: MA

Zip: 02140

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$80M

Raised Total:

$257M

Metrics

2,675,031Website Global Rank

6,566Website Monthly Traffic

Twitter Followers

Description

Genocea is a pharmaceutical company that researches and develops T-cell based therapies for the treatment of cancer.

Contact Phone:
+16178768191

Contact Email:

Genocea went public on 2/6/2014 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
2/6/2014

IPO Valuation:
$207M

Ticker Symbol:
GNCA

IPO Price:
$13/share

Amount Raised:
$66M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
10/2012 Series C 12 $30M SR One
Skyline Ventures
Sahsen Ventures
Polaris Partners
MP Healthcare Venture Management
Morningside Group
Lux Capital
Johnson &a; Johnson Development Corporation
Cycad Group
CVF
SR One
Skyline Ventures
Sahsen Ventures
Polaris Partners
MP Healthcare Venture Management
Morningside Group
Lux Capital
Johnson &a; Johnson Development Corporation
Cycad Group
CVF
12/2009 Series B 8 $25.7M SR One
Skyline Ventures
Polaris Partners
MP Healthcare Venture Management
Lux Capital
Johnson &a; Johnson Development Corporation
Cycad Group
Auriga Partners
SR One
Skyline Ventures
Polaris Partners
MP Healthcare Venture Management
Lux Capital
Johnson &a; Johnson Development Corporation
Cycad Group
Auriga Partners
1/2011 Series B 8 $35M SR One
Skyline Ventures
Polaris Partners
MP Healthcare Venture Management
Morningside Group
Lux Capital
Johnson &a; Johnson Development Corporation
Cycad Group
SR One
Skyline Ventures
Polaris Partners
MP Healthcare Venture Management
Morningside Group
Lux Capital
Johnson &a; Johnson Development Corporation
Cycad Group
2/2019 Post-IPO Equity $39.2M
9/2014 Grant 1 $1.2M Bill &a; Melinda Gates Foundation
Bill &a; Melinda Gates Foundation
11/2014 Post-IPO Debt $27M
3/2015 Post-IPO Equity $51.7M
7/2015 Post-IPO Equity $50M
10/2013 Series D 1 $16.1M Auriga Partners
Auriga Partners
Auriga Partners
Auriga Partners
7/2014 Post-IPO Equity -
7/2020 Post-IPO Equity $80M
6/2019 Post-IPO Equity $36.8M
1/2018 Post-IPO Equity $55M
5/2018 Debt $14M Hercules Capital, Inc.
2/2009 Series A 7 $23M SR One
Real Estate Equities
Polaris Partners
Morningside Group
Lux Capital
Cycad Group
Auriga Partners
SR One
Real Estate Equities
Polaris Partners
Morningside Group
Lux Capital
Cycad Group
Auriga Partners
2/2019 Equity $12.1M JSB Partners LLC
2/2014 IPO $66M
9/2013 Unattributed $400k
7/2020 Equity $75.5M JSB Partners LLC
7/2014 Post-IPO Equity -
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research